A review of the symptomatic management of malignant gliomas in adults.
Publication/Presentation Date
4-1-2013
Abstract
Malignant brain tumors are aggressive tumors with a very poor prognosis. Survival is on average 12 to 18 months. Patients with malignant gliomas are subject to multiple medical problems that can significantly impact their overall survival and quality of life, including seizures, cerebral edema, venous thromboembolism, cognitive and psychiatric disorders, and side effects of chemotherapy, such as nausea, vomiting, myelosuppression, constipation, and diarrhea. This article examines the evidence for managing many of these issues to reduce symptoms and improve quality of life.
Volume
11
Issue
4
First Page
424
Last Page
429
ISSN
1540-1413
Published In/Presented At
Shah, U., & Morrison, T. (2013). A review of the symptomatic management of malignant gliomas in adults. Journal of the National Comprehensive Cancer Network : JNCCN, 11(4), 424–429. https://doi.org/10.6004/jnccn.2013.0057
Disciplines
Medicine and Health Sciences
PubMedID
23584345
Department(s)
Department of Medicine
Document Type
Article